Keith DiPetrillo

Trailblazer
DISC Type : ID

Scientific Director, NonClinical Safety at Bristol Myers Squibb

Phillipsburg, New Jersey, United States

Overview

Keith DiPetrillo is a Scientific Director at Bristol Myers Squibb, specializing in nonclinical safety and toxicology. An innovative and creative pharmacologist with a PhD from Dartmouth, he has a strong record of leading teams to advance drug compounds into clinical trials, particularly in oncology and cardiovascular diseases. People often describe him as skilled, knowledgeable, and pragmatic.

Outside of his scientific work, Keith is committed to supporting health-related causes. He actively participates in and raises funds for the American Heart Associations Heart Walk, demonstrating a personal investment in advancing cardiovascular research and community well-being.

He is the editor of a book titled "Cardiovascular Genomics: Methods and Protocols, " part of the Methods in Molecular Biology series.

Personality Overview

Values Relationships

Charismatic

Friendly But Fast

They respond better to a combination of speed and relationship.  They are more likely to be open to unproven but exciting technologies. They are charming and have the ability to align others behind their decisions.

Topics They Care About

Drug Discovery
His career is focused on identifying and advancing lead compounds (small molecules and biologics) into clinical trials across multiple therapeutic areas.
Nonclinical Safety
His current role is Scientific Director of NonClinical Safety, serving as the project toxicologist for multiple drug development programs in oncology and neuroscience.
Cardiovascular Health
He actively fundraises for the American Heart Association and has edited a book on cardiovascular genomics, showing a deep professional and personal interest.

Media Appearances

Keith has no verified media appearances

Work History

11-2024
Scientific Director, NonClinical Safety at Bristol Myers Squibb
8-2020 - 11-2024
Scientific Director, Discovery Toxicology at Bristol Myers Squibb
3-2018 - 8-2020
Director, Translational Safety In Vivo Models at Novartis Institutes for BioMedical Research (NIBR)
1-2016 - 2-2018
Director, Discovery Pharmacology at Insmed Incorporated
5-2005 - 12-2015
Senior Investigator I at Novartis Institutes for BioMedical Research (NIBR)

Education

1998 - 2002
PhD from Geisel School of Medicine at Dartmouth
1993 - 1998
BS from University of Rhode Island

More Information

Social Presence :

Prographics :

Exp : 27 Location : Phillipsburg, New Jersey, United States Job Level : Mid-senior Designation : Scientific Director, NonClinical Safety at Bristol Myers Squibb
URL has been copied!

Insights For Selling To Keith

During A Call Or A Meeting

DO's

  • Address your competition clearly and confidently
  • Ask them for a lunch or coffee once some rapport has been established
  • Display high self-confidence and expect them to have a strong personality.

DONT's

  • Don't make any commitments that you might not be able to fulfill
  • Don’t hesitate from asking questions or pushing them, but take a friendly approach
  • Avoid unnecessary negativity or slowness

When Cold Calling

When Writing An Email

While Negotiating & Closing

    The secret to closing fast with Keith is

  • Relationship and product conviction matter equally, followed by a sense of achievement.
  • Will you ever get a clear answer from Keith

  • If they are not convinced, they will say no albeit in a friendly manner.


Insights For Deal Planning

    How fast (or slow) will Keith move?

  • They can reach decisions quickly if they develop trust and confidence in the product.
  • Can Keith take some risk or not?

  • They can take risks if necessary.

You And Keith

Personality Compatibility


Other Bristol Myers Squibb Employees

Explore more public profiles from related professionals at the same organization.

More Profiles

Discover additional public profiles from our index.

Search more profiles

Looking for someone else? Search here for anyone.

Or visit Humantic AI to know more.